Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 1
1999 1
2000 2
2001 3
2002 1
2003 10
2004 10
2005 12
2006 3
2007 24
2008 19
2009 20
2010 24
2011 26
2012 31
2013 24
2014 31
2015 27
2016 38
2017 40
2018 40
2019 39
2020 38
2021 36
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

448 results
Results by year
Filters applied: . Clear all
Page 1
PCSK9 inhibitors and cardiovascular outcomes.
Steffens D, Bramlage P, Scheeff C, Kasner M, Hassanein A, Friebel J, Rauch-Kröhnert U. Steffens D, et al. Expert Opin Biol Ther. 2020 Jan;20(1):35-47. doi: 10.1080/14712598.2020.1677604. Epub 2019 Oct 18. Expert Opin Biol Ther. 2020. PMID: 31593483
Natural course of tricuspid regurgitation and prognostic implications.
Bannehr M, Edlinger CR, Kahn U, Liebchen J, Okamoto M, Hähnel V, Dworok V, Schipmann F, Kücken T, Bramlage K, Bramlage P, Haase-Fielitz A, Butter C. Bannehr M, et al. Open Heart. 2021 Feb;8(1):e001529. doi: 10.1136/openhrt-2020-001529. Open Heart. 2021. PMID: 33563777 Free PMC article.
Survival was worst in patients with moderate and severe TR and concomitant elevated sPAP or reduced LV-EF at 1 and 3 years, respectively (p<0.001; p<0.001). In a multivariate model, including cardiac and non-cardiac risk factors, moderate and severe TR, sPAP a …
Survival was worst in patients with moderate and severe TR and concomitant elevated sPAP or reduced LV-EF at 1 and 3 years, respectively ( …
[Perioperative management of anticoagulation].
Eisele R, Melzer N, Bramlage P. Eisele R, et al. Chirurg. 2014 Jun;85(6):513-9. doi: 10.1007/s00104-014-2738-6. Chirurg. 2014. PMID: 24823997 Review. German.
Management of patients with severe aortic stenosis in the TAVI-era: how recent recommendations are translated into clinical practice.
Lauten A, Rudolph TK, Messika-Zeitoun D, Thambyrajah J, Serra A, Schulz E, Frey N, Maly J, Aiello M, Lloyd G, Bortone AS, Clerici A, Delle-Karth G, Rieber J, Indolfi C, Mancone M, Belle L, Arnold M, Bouma BJ, Lutz M, Deutsch C, Kurucova J, Thoenes M, Bramlage P, Steeds RP. Lauten A, et al. Open Heart. 2021 Jan;8(1):e001485. doi: 10.1136/openhrt-2020-001485. Open Heart. 2021. PMID: 33431618 Free PMC article.
Denial was independently associated with multiple factors, including severe frailty (p=0.024); mitral (p=0.002) or tricuspid (p=0.004) regurgitation grade III/IV, and the presence of renal impairment (p=0.017). ...Regardless, 36.3% were assigned to val …
Denial was independently associated with multiple factors, including severe frailty (p=0.024); mitral (p=0.002) or tricuspid ( …
Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure.
Kolwelter J, Bosch A, Jung S, Stabel L, Kannenkeril D, Ott C, Bramlage P, Schiffer M, Achenbach S, Schmieder RE. Kolwelter J, et al. ESC Heart Fail. 2021 Dec;8(6):5327-5337. doi: 10.1002/ehf2.13622. Epub 2021 Sep 20. ESC Heart Fail. 2021. PMID: 34544205 Free PMC article. Clinical Trial.

Vascular parameters such as central systolic blood pressure (cSBP), central pulse pressure (cPP), forward (FPH), and reflected pressure pulse height (RPH) decreased under resting conditions after 1 and 3 months (1 month: cSBP -6.4 8.3 mmHg, P < 0.001, cPP -3.0 6.6 mmHg,

…
Vascular parameters such as central systolic blood pressure (cSBP), central pulse pressure (cPP), forward (FPH), and reflected pressure puls …
Aortic valve replacement: validation of the Toronto Aortic Stenosis Quality of Life Questionnaire.
Frank D, Kennon S, Bonaros N, Stastny L, Romano M, Lefèvre T, Di Mario C, Stefàno P, Ribichini F, Himbert D, Urena-Alcazar M, Salgado-Fernandez J, Castillo JJC, Garcia Del Blanco B, Deutsch C, Sykorova L, Kurucova J, Thoenes M, Lüske CM, Bramlage P, Styra R. Frank D, et al. ESC Heart Fail. 2021 Feb;8(1):270-279. doi: 10.1002/ehf2.12961. Epub 2020 Nov 18. ESC Heart Fail. 2021. PMID: 33207035 Free PMC article.

Mean TASQ score at baseline was 71.2 points and increased to 88.9 three months after aortic valve implantation (P < 0.001). Increases were seen for the emotional impact (32.0 to 39.0; P < 0.001), physical limitations (14.8 to 22.0; P < 0.001), and ph

…

Mean TASQ score at baseline was 71.2 points and increased to 88.9 three months after aortic valve implantation (P < 0.001). Increa

…
IMPULSE: the impact of gender on the presentation and management of aortic stenosis across Europe.
Steeds RP, Messika-Zeitoun D, Thambyrajah J, Serra A, Schulz E, Maly J, Aiello M, Rudolph TK, Lloyd G, Bortone AS, Clerici A, Delle-Karth G, Rieber J, Indolfi C, Mancone M, Belle L, Lauten A, Arnold M, Bouma BJ, Lutz M, Deutsch C, Kurucova J, Thoenes M, Bramlage P, Frey N; IMPULSE registry group. Steeds RP, et al. Open Heart. 2021 Jan;8(1):e001443. doi: 10.1136/openhrt-2020-001443. Open Heart. 2021. PMID: 33419934 Free PMC article.
Women were characterised by a higher rate of renal impairment (31.7 vs 23.3%; p<0.001), were at higher surgical risk (EuroSCORE II: 4.5 vs 3.6%; p=0.001) and more often in a critical preoperative state (7.0vs 4.2%; p=0.003). Men had an increased rate of pr …
Women were characterised by a higher rate of renal impairment (31.7 vs 23.3%; p<0.001), were at higher surgical risk (EuroSCORE II …
Impact of Rehabilitation on Outcomes after TAVI: A Preliminary Study.
Butter C, Groß J, Haase-Fielitz A, Sims H, Deutsch C, Bramlage P, Neuss M. Butter C, et al. J Clin Med. 2018 Oct 5;7(10):326. doi: 10.3390/jcm7100326. J Clin Med. 2018. PMID: 30301135 Free PMC article.
Mortality at six months was lower for patients receiving rehabilitation compared with those who had not (adjusted odds ratio (OR): 0.49; 95% confidence interval (confidence interval [CI]: 0.25-0.94; p = 0.032). Sub-analysis showed the benefit of cardiac (adjusted OR: 0.31; …
Mortality at six months was lower for patients receiving rehabilitation compared with those who had not (adjusted odds ratio (OR): 0.49; 95% …
Impact of selected comorbidities on the presentation and management of aortic stenosis.
Rudolph TK, Messika-Zeitoun D, Frey N, Thambyrajah J, Serra A, Schulz E, Maly J, Aiello M, Lloyd G, Bortone AS, Clerici A, Delle-Karth G, Rieber J, Indolfi C, Mancone M, Belle L, Lauten A, Arnold M, Bouma BJ, Lutz M, Deutsch C, Kurucova J, Thoenes M, Bramlage P, Steeds RP. Rudolph TK, et al. Open Heart. 2020 Jul;7(2):e001271. doi: 10.1136/openhrt-2020-001271. Open Heart. 2020. PMID: 32709699 Free PMC article.
The decision to perform aortic valve replacement (AVR) was taken in a comparable proportion (67%, 72% and 69%, in patients with 0, 1 and 2 comorbidities; p=0.186). However, the decision for TAVI was more common with more comorbidities (35.4%, 54.0% and 57.0% for no, 1 and …
The decision to perform aortic valve replacement (AVR) was taken in a comparable proportion (67%, 72% and 69%, in patients with 0, 1 and 2 c …
448 results